Case Report
Published on 14 Jul 2023
Effect of anlotinib combined with ticeorgio for recurrent nasopharyngeal carcinoma: a case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166809
- 1,579 views
Type at least 3 characters
2,601 articles
Articles
Original Research
Published on 13 Jul 2023
Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1162563
- 3,502 views
- 2 citations
Editorial
Published on 13 Jul 2023
Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1252168
- 1,189 views
- 1 citation
Systematic Review
Published on 13 Jul 2023
Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163805
- 3,006 views
- 3 citations
Review
Published on 13 Jul 2023
Should oncologists trust cannabinoids?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1211506
- 4,613 views
- 6 citations
Original Research
Published on 13 Jul 2023
Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192434
- 7,174 views
- 8 citations
Original Research
Published on 12 Jul 2023
Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1144632
- 3,145 views
Original Research
Published on 11 Jul 2023
Identification of collateral sensitivity and evolutionary landscape of chemotherapy-induced drug resistance using cellular barcoding technology
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178489
- 2,903 views
- 5 citations
Mini Review
Published on 07 Jul 2023
New insights into the therapeutic potentials of statins in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188926
- 6,794 views
- 11 citations
Review
Published on 07 Jul 2023
Lysosomes, curcumin, and anti-tumor effects: how are they linked?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1220983
- 3,905 views
- 5 citations
Review
Published on 06 Jul 2023
New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228962
- 6,119 views
- 8 citations
Systematic Review
Published on 06 Jul 2023
Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in Asian populations: a systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1212313
- 5,263 views
- 5 citations
Mini Review
Published on 05 Jul 2023
Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1212986
- 4,734 views
- 9 citations
Original Research
Published on 04 Jul 2023
Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164425
- 4,571 views
- 8 citations
Original Research
Published on 04 Jul 2023
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1212392
- 4,294 views
Review
Published on 30 Jun 2023
Icariin as a potential anticancer agent: a review of its biological effects on various cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1216363
- 4,756 views
- 8 citations